Effect of Renin–Angiotensin System Inhibition on Cardiovascular Events in Older Hypertensive Patients with Metabolic Syndrome

Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients

New England Journal of Medicine · 2000 · 8.7K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

The Metabolic Syndrome and Total and Cardiovascular Disease Mortality in Middle-aged Men

Hanna‐Maaria Lakka · JAMA · 2002 · 5.1K citations

Medicine, Cardiology, Endocrinology +17

The cardiovascular health study: Design and rationale

Linda P. Fried, Nemat O. Borhani, Paul Enright et al. · Annals of Epidemiology · 1991 · 3.7K citations

Medicine, Cardiology, Clinical Cardiology +5

Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study)

Kim Fox · The Lancet · 2003 · 2.2K citations

Medicine, Cardiology, Pharmacotherapy +13

The Metabolic Syndrome

Yong-Woo Park, Shankuan Zhu, Latha Palaniappan et al. · Archives of Internal Medicine · 2003 · 2.1K citations

Medicine, Endocrinology, Nutrition +17